Northeast Ohio investment climate not ideal for bioscience

A high-risk, high-return drug testing company chose to locate in Northeast Ohio because the principals liked the easy-going Midwest flavor of the region. But they’re finding that along with the slower pace, the investment attitude is extremely conservative and somewhat stuck in the past.

Read this interview with Arnon Chait, CEO of Analiza, Inc. on